Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jun 11, 2003	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0000891092-03-001290.pdf 0000891092-03-001290.rtf
Jun 5, 2003	8-K	Report of unscheduled material events or corporate event	View HTML 0000891092-03-001260.pdf 0000891092-03-001260.rtf
May 15, 2003	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000891092-03-001074.pdf 0000891092-03-001074.rtf
May 2, 2003	REGDEX	REGDEX	View HTML 9999999997-03-020389.pdf 9999999997-03-020389.rtf
Mar 26, 2003	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000891092-03-000483.pdf 0000891092-03-000483.rtf
Mar 4, 2003	8-K	Report of unscheduled material events or corporate event	View HTML 0000905718-03-000134.pdf 0000905718-03-000134.rtf
Feb 13, 2003	8-K/A	Amendment to a previously filed 8-K	View HTML 0000905718-03-000086.pdf 0000905718-03-000086.rtf
Feb 12, 2003	8-K	Report of unscheduled material events or corporate event	View HTML 0000905718-03-000064.pdf 0000905718-03-000064.rtf
Nov 19, 2002	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000905718-02-000392.pdf 0000905718-02-000392.rtf
Nov 15, 2002	NT 10-Q	Notification that form type 10-Q will be submitted late	View HTML 0000905718-02-000387.pdf 0000905718-02-000387.rtf